KiwiSaver provider Pathfinder can’t kick the habit – and nor can the FMA.
The buyer’s financing reveals some healthy returns on offer.
The $400m government scheme has a lot of work to do.
Fletcher Building goes fuzzy with $300m.
Companies may benefit from external scrutiny, even if they pay for it.
The company’s obscure sales model has turned into a major weakness.
The co-op’s restructuring proposal is ingenious, but difficult.
Westpac’s potential NZ spin-out should be a model for others.
The Nasdaq-listed parent company is a hot mess of dodgy finances and vague disclosures.
No-one should be surprised by high power prices when lakes are low.